Role of cysteinyl leukotriene signaling in a mouse model of noise-induced cochlear injury

Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9911-6. doi: 10.1073/pnas.1402261111. Epub 2014 Jun 23.

Abstract

Noise-induced hearing loss is one of the most common types of sensorineural hearing loss. In this study, we examined the expression and localization of leukotriene receptors and their respective changes in the cochlea after hazardous noise exposure. We found that the expression of cysteinyl leukotriene type 1 receptor (CysLTR1) was increased until 3 d after noise exposure and enhanced CysLTR1 expression was mainly observed in the spiral ligament and the organ of Corti. Expression of 5-lipoxygenase was increased similar to that of CysLTR1, and there was an accompanying elevation of CysLT concentration. Posttreatment with leukotriene receptor antagonist (LTRA), montelukast, for 4 consecutive days after noise exposure significantly decreased the permanent threshold shift and also reduced the hair cell death in the cochlea. Using RNA-sequencing, we found that the expression of matrix metalloproteinase-3 (MMP-3) was up-regulated after noise exposure, and it was significantly inhibited by montelukast. Posttreatment with a MMP-3 inhibitor also protected the hair cells and reduced the permanent threshold shift. These findings suggest that acoustic injury up-regulated CysLT signaling in the cochlea and cochlear injury could be attenuated by LTRA through regulation of MMP-3 expression. This study provides mechanistic insights into the role of CysLTs signaling in noise-induced hearing loss and the therapeutic benefit of LTRA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / therapeutic use
  • Animals
  • Cochlea / injuries*
  • Cyclopropanes
  • Cysteine / metabolism*
  • Disease Models, Animal*
  • Gene Expression Profiling
  • Leukotriene Antagonists / therapeutic use
  • Leukotrienes / metabolism*
  • Matrix Metalloproteinase 3 / metabolism
  • Mice
  • Noise / adverse effects*
  • Quinolines / therapeutic use
  • Receptors, Leukotriene / drug effects
  • Signal Transduction*
  • Sulfides
  • Wounds and Injuries / drug therapy
  • Wounds and Injuries / etiology

Substances

  • Acetates
  • Cyclopropanes
  • Leukotriene Antagonists
  • Leukotrienes
  • Quinolines
  • Receptors, Leukotriene
  • Sulfides
  • cysteinyl-leukotriene
  • Matrix Metalloproteinase 3
  • Cysteine
  • leukotriene D4 receptor
  • montelukast